ABO and Alzheimer disease: We verified the results in AβO-treated, AβO- and scramble and functional AdipoR1 shRNA-treated, and APP/PS1 mice, in in vitro AβO and APPswe/ind overexpression AD models, and in HFD and Adipo−/− mice.